Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Chemistry

• Publication date

  2001-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/CLINCHEM/47.6.1102PMID 11375298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Homocysteine and Risk of Cardiovascular Disease

  2004cited by this paper
• Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.

  2001cited by this paper
• Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to Excitotoxicity

  2000cited by this paper
• Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD

  2000cited by this paper
• Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa.

  2000cited by this paper
• Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.

  1999cited by this paper
• Nigral endothelial dysfunction, homocysteine, and Parkinson's disease.

  1999cited by this paper
• Elevated Plasma Levels of Homocysteine inParkinson’s Disease

  1998cited by this paper
• Hyperhomocysteinaemia in Parkinson’s disease

  1998cited by this paper
• [Homocysteine as a risk factor for atherosclerosis].

  1997cited by this paper
• Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats.

  1997cited by this paper
• Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection.

  1997cited by this paper
• Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.

  1997cited by this paper
• [Evaluation of vascular risk factors in patients with Parkinson syndrome].

  1997cited by this paper
• Evaluation vaskulärer Risikofaktoren bei Patienten mit Parkinson-Syndrom

  1997cited by this paper
• Oxidative stress and the pathogenesis of Parkinson's disease

  1996cited by this paper
• Homocysteine mediated endothelial cell toxicity and its amelioration.

  1996cited by this paper
• Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disorders.

  1995cited by this paper
• Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.

  1995cited by this paper
• Sulfate and cysteine levels in the plasma of patients with Parkinson's disease.

  1995cited by this paper
• l‐DOPA Cytotoxicity to PC12 Cells in Culture Is via Its Autoxidation

  1995cited by this paper
• Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

  1995cited by this paper
• Hyperhomocysteinaemia; with reference to its neuroradiological aspects

  1995cited by this paper
• S‐adenosylmethionine levels in psychiatric and neurological disorders: a review

  1994cited by this paper
• L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity?

  1994cited by this paper
• The effects of L-dopa on the activity of methionine adenosyltransferase: Relevance to L-dopa therapy and tolerance

  1993cited by this paper
• Stroke and Parkinson's Disease

  1992cited by this paper
• Quantification of neurologic deficit

  1990cited by this paper
• Functional methionine synthase deficiency (cblE and cblG): clinical and biochemical heterogeneity.

  1989cited by this paper
• Quantification of neurologic deficit

  1989cited by this paper
• A rapid and simple method for determining catecholamines in human plasma and cerebrospinal fluid using high-performance liquid chromatography with electrochemical detection.

  1986cited by this paper
• Assessment of Parkinson's Disease

  1984cited by this paper
• J Ournal of Clinical and Basic Cardiology Krause & Pachernegg Gmbh · Verlag Für Medizin Und Wirtschaft · A-3003 Gablitz/austria Homocysteine and Risk of Cardiovascular Disease

  year unknowncited by this paper

• Exploring Phytomedicine’s Potential in Managing Parkinson’s Disease: Unveiling Neuroprotective Compounds from Medicinal Plants

  2025cites this paper
• Swept-Source Optical Coherence Tomography and Optical Coherence Tomography Angiography Findings in Patients with Solar Retinopathy.

  2025cites this paper
• The Role of Serum Vitamin and Mineral Levels in Benign Essential Blepharospasm: A Comparative Study.

  2025cites this paper
• Features of Plasma Homocysteine, Vitamin B12, and Folate in Parkinson's Disease: An Updated Meta-Analysis.

  2023cites this paper
• Striatal astrocytic A2A-D2 receptor-receptor interactions and their role in neuropsychiatric disorders.

  2023cites this paper
• Two Faces of Catechol-O-Methyltransferase Inhibitor on One-Carbon Metabolism in Parkinson’s Disease: A Meta-Analysis

  2023cites this paper
• Homocysteine and Dementia in Parkinson Disease

  2022cites this paper
• How Does Entacapon Affect Homocysteine Levels?

  2021influential citation
• The modulatory effect and implication of gut microbiota on osteoporosis: from the perspective of "brain-gut-bone" axis.

  2021cites this paper
• Metabolism of Sulfur-Containing Amino Acids: How the Body Copes with Excess Methionine, Cysteine, and Sulfide.

  2020cites this paper
• Cognitive and motor correlates of grey and white matter pathology in Parkinson’s disease

  2020cites this paper
• Cell Ratio Differences in Peripheral Blood between Early- and Late-Onset Parkinson's Disease: A Case-Control Study

  2019cites this paper
• Nutritional Status and Dialysis Modality: Effect on Folate Status 20 Years after the Institution of a National Folic Acid Fortification Program

  2019cites this paper
• MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies.

  2018cites this paper
• Evaluation of Antioxidant Properties of Hydroalcoholic Extract of Purslane (Portulaca oleracea) and Its Protective Effect on 6-Hydroxydopamine Induced Hepatic Damage in Parkinsonian Male Rats

  2018cites this paper
• Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes

  2018cites this paper
• The anxiolytic effects of atorvastatin and simvastatin on dietary-induced increase in homocysteine levels in rats

  2018cites this paper
• Association of Hyperhomocysteinemia with L-DOPA treated Parkinson Disease patients from India : Finding the relation whether it ’ s a cause or consequence ? Chapter 4 Dementia : Advances and Treatment

  2018cites this paper
• Homocysteine Serum Levels and Methylenetetrahydrofolate (MTHFR) C677T Genotype in Patients with Parkinson's Disease, with and without Levodopa Therapy

  2018influential citation
• Interplay between Glucocerebrosidase 1 and Glucocerebrosidase 2; potential implications for the pathogenesis of Gaucher and Parkinson's diseases

  2017cites this paper
• Falls, fractures and bone density in Parkinson's disease – a cross-sectional study

  2017cites this paper
• Important medicinal herbs in Parkinson's disease pharmacotherapy.

  2017cites this paper
• The Effects of Methionine-Enriched and Vitamins (Folate, Pyridoxine and Cobalamine)-Deficient Diet on Exploratory Activity in Rats - A Brief Report

  2017cites this paper
• L-DOPA-induced hyperhomocysteinemia in Parkinson's disease: Elephant in the room.

  2016cites this paper
• Parkinson's Disease and Homocysteine: A Community-Based Study in a Folate and Vitamin B12 Deficient Population

  2016cites this paper
• HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON’S DISEASE

  2016cites this paper
• Metabonomic study of rats exposed to cigarette sidestream smoke

  2016cites this paper
• Epigenetic Significance of Chromatin Organization During Cellular Aging and Organismal Lifespan

  2016cites this paper
• Vascular Endothelial Cells as Biomarkers of Microvascular Endothelium Damage and Repair in Cardiovascular and Neurodegenerative Diseases

  2016cites this paper
• DNA Methylation in Psychiatric Diseases

  2015cites this paper
• Beneficial antioxidant properties of betaine against oxidative stress mediated by levodopa/benserazide in the brain of rats

  2015cites this paper
• Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in rats

  2015influential citation
• Research Article / Araştirma Makalesi

  2015cites this paper
• Garcinol prevents hyperhomocysteinemia and enhances bioavailability of L-DOPA by inhibiting catechol-O-methyltransferase: an in silico approach

  2015cites this paper
• Conséquences d’une carence en donneurs de méthyles sur la différenciation neuronale et la plasticité : influence d’une supplémentation périnatale sur le développement cérébral

  2015cites this paper
• Oxidative Medicine and Cellular Longevity 3 High fat diet and obesity Hyperglycemia and diabetes High level inflammations Hyperhomocysteinemia and endothelial dysfunction Risk factors Oxidative stress Antioxidants

  2014cites this paper
• Is Peripheral Neuropathy occurring in association with Idiopathic Parkinson's Disease, an iatrogenic complication?

  2014cites this paper
• Parkinson’s Disease and Peripheral Neuropathy

  2014cites this paper
• Physical exercise and Parkinson’s disease: influence on symptoms, disease course and prevention

  2013cites this paper
• Ostéoporose et maladie de Parkinson

  2013cites this paper
• Homocysteine Level and Mechanisms of Injury in Parkinson's Disease as Related to MTHFR, MTR, and MTHFD1 Genes Polymorphisms and L-Dopa Treatment

  2013cites this paper
• DNA methylation, a hand behind neurodegenerative diseases

  2013cites this paper
• Vitamin B12 in neurology and ageing; clinical and genetic aspects.

  2013cites this paper
• Elevated homocysteine levels in levodopa‐treated idiopathic Parkinson's disease: a meta‐analysis

  2013cites this paper
• Conséquence d'une carence gestationnelle en donneurs de méthyles sur l'expression des protéines clés de la neurostéroïdogenèse chez le rat

  2013cites this paper
• Epigenetics in Parkinson's and Alzheimer's diseases.

  2013cites this paper
• Epigenetic Landscape of Parkinson’s Disease: Emerging Role in Disease Mechanisms and Therapeutic Modalities

  2013cites this paper
• Interaction of Memantine with Homocysteine on the Apoptosis in the Rat Hippocampus cells

  2012cites this paper
• Effects of Exercise and B Vitamins on Homocysteine and Glutathione in Parkinson’s Disease: A Randomized Trial

  2012cites this paper
• Idiopathic Parkinson's Disease, Vascular Risk Factors and Cognition: A Critical Review

  2012cites this paper
• Methionine-enriched diet decreases hippocampal antioxidant defences and impairs spontaneous behaviour and long-term potentiation in rats.

  2012cites this paper
• Epigenetics in neurodegeneration: a new layer of complexity.

  2011cites this paper
• Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.

  2011cites this paper
• Blood-Based Protein Biomarkers for Diagnosis and Classification of Neurodegenerative Diseases

  2011influential citation
• DNA methylation in neurodegenerative disorders: a missing link between genome and environment?

  2011cites this paper
• Serum homocysteine and physical exercise in patients with Parkinson's disease

  2011cites this paper
• Hyperhomocysteinemia Due to Levodopa Treatment as a Risk Factor for Osteoporosis in Patients with Parkinson’s Disease

  2010cites this paper
• Homocysteine‐lowering therapy or antioxidant therapy for bone loss in Parkinson's disease

  2010cites this paper
• Catechol-O-methyltransferase enzyme: cofactor S-adenosyl-L-methionine and related mechanisms.

  2010cites this paper
• Elevated Levels of Methylmalonate and Homocysteine in Parkinson’s Disease, Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis

  2010cites this paper
• Einfluss des Homocystein-Stoffwechsels auf neurodegenerative Erkrankungen: Homocystein- und Methylierungsstatus bei Patienten mit Morbus Parkinson

  2010cites this paper
• Effect of entacapone on plasma homocysteine levels in Parkinson’s disease patients

  2010cites this paper
• Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients.

  2009cites this paper
• Retracted: Brain Damage in Phenylalanine, Homocysteine and Galactose Metabolic Disorders

  2009cites this paper
• Methylation status and neurodegenerative markers in Parkinson disease.

  2009cites this paper
• Osteoporosis in Parkinson's disease.

  2009cites this paper
• Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson´s disease

  2009cites this paper
• Calcium Homeostasis Is Dysregulated in Parkinsonian Patients With l-DOPA-Induced Dyskinesias

  2009cites this paper
• Genetic and environmental factors for hyperhomocysteinaemia and its clinical implications in Parkinson's disease.

  2009cites this paper
• Conséquences d'une carence en donneurs de méthyles sur la différenciation cellulaire, la survie et la neuroplasticité : approches mécanistiques in vitro sur des lignées neuronales

  2009cites this paper
• The Relationship Between Plasma Homocysteine Level and C677T MTHFR Genotype in Drug-Naive Patients With Idiopathic Parkinson's Disease

  2008cites this paper
• [Folic acid in physiology and pathology].

  2008cites this paper
• Neuropathy as a potential complication of levodopa use in Parkinson's disease

  2008cites this paper
• Kwas foliowy w fi zjologii i patologii Folic acid in physiology and pathology

  2008cites this paper
• Role of homocysteine in the treatment of Parkinson's disease

  2008cites this paper
• Evaluation of the Current Evidence on Hyperhomocysteinaemia in Neurological Diseases

  2008cites this paper
• Folate and vitamin B12 levels in levodopa-treated Parkinson's disease patients: their relationship to clinical manifestations, mood and cognition.

  2008cites this paper
• 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson's disease.

  2007cites this paper
• Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review

  2007cites this paper
• The Influence of Levodopa and the COMT Inhibitor on Serum Vitamin B12 and Folate Levels in Parkinson’s Disease Patients

  2007cites this paper
• The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases

  2007cites this paper
• [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations].

  2007cites this paper
• Homocysteine and Parkinson's disease: a dangerous liaison?

  2007cites this paper
• THE ROLE OF HOMOCYSTEINE IN HEALTH AND DISEASE

  2007cites this paper
• Chapter 10 – The Role of Levodopa in the Chronic Neurodegenerative Disorder – Parkinson's Disease

  2007cites this paper
• Hyperhomocysteinämie und B-Vitaminmangel bei neurologischen und psychiatrischen Erkrankungen

  2007cites this paper
• Drug Treatment of Motor Symptoms in Parkinson's Disease

  2007cites this paper
• The role of complementary vitamins, folate, vitamin B6, and vitamin B12, in cardiovascular disease.

  2006cites this paper
• Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations

  2006cites this paper
• Plasma Homocysteine Levels and Parkinson Disease: Disease Progression, Carotid Intima-media Thickness and Neuropsychiatric Complications

  2006cites this paper
• Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors.

  2006cites this paper
• Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy.

  2006cites this paper
• Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients.

  2005cites this paper
• Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease.

  2005cites this paper
• The significance of folic acid for epilepsy patients.

  2005cites this paper
• Carotid dissection causing occipital lobe infarction

  2005cites this paper
• Homocysteine and Redox Signaling

  2005cites this paper
• Endothelial function markers in parkinsonian patients with hyperhomocysteinemia.

  2005cites this paper
• The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats

  2005cites this paper
• Association of homocysteine with plasma amyloid β protein in aging and neurodegenerative disease

  2005cites this paper